Filter
526
Filtered Results: 526
Text search:
management
of
latent
TB
Featured
Recommendations
59
New Publications
146
Language
Document type
No document type
403
Guidelines
51
Studies & Reports
36
Manuals
16
Strategic & Response Plan
7
Fact sheets
6
Training Material
4
Situation Updates
2
Online Courses
1
Countries / Regions
Western and Central Europe
30
India
29
Eastern Europe
16
South Africa
15
Tanzania
14
Nepal
12
Kenya
9
Ethiopia
8
Nigeria
7
Latin America and the Carribbean
7
Zambia
6
Bangladesh
6
Namibia
6
Ukraine
6
Global
6
Philippines
5
Myanmar / Burma
5
Russia
5
Sierra Leone
4
Liberia
4
Germany
4
Rwanda
4
Malawi
4
Argentina
4
Botswana
4
South–East Asia Region
4
Ghana
3
Uganda
3
Cambodia
3
Colombia
3
East and Southern Africa
3
Asia
3
Africa
3
Zimbabwe
2
Brazil
2
El Salvador
2
Lesotho
2
West and Central Africa
2
Albania
2
Timor Leste/ East Timor
2
Guinea
1
Senegal
1
USA
1
Cameroon
1
South Sudan
1
Gambia
1
Indonesia
1
Peru
1
Eswatini/ Swaziland
1
Switzerland
1
Sri Lanka
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
North Korea
1
Estonia
1
Romania
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
161
Clinical Guidelines
68
Public Health
17
Women & Child Health
9
Pharmacy & Technologies
6
Key Resources
4
Capacity Building
3
Toolboxes
TB
268
HIV
65
Refugee
13
Polio
11
COVID-19
8
Ebola
7
Pharmacy
6
NTDs
6
AMR
4
Disability
3
Conflict
3
Rapid Response
3
Mental Health
3
Global Health Education
3
Caregiver
3
Planetary Health
3
NCDs
3
Specific Hazards
2
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited a...
Southern African Journal of HIV Medicine
ISSN: (Online) 2078-6751, (Print) 1608-9693
http://www.sajhivmed.org.za
Published: 23 May 2018
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care ... HIV-positive adults. They should be read in conjunction with other published BHIVA guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure.
The 2019 interim statement provides updated advice on treatment with two-drug regimens
The Global Reference List of 100 Core Health Indicators is a standard set of core indicators prioritized by the global community to provide concise information on the health situation and trends, in...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the hea...
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development...
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array ... disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases.
The List is divided into two sections depending on the user and setting: one for community settings, which includes self-testing; and a second one for clinical laboratories, which can be general and specialized facilities.
No Public Health without Refugee and Migrant health.
This report, the first of its kind, creates an evidence base with the aim of catalysing progress towards developing and promoting migrant-sensit...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used ...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most ... these diseases and conditions are at least partially caused by the environment. It was estimated in 2012 that 26% of childhood deaths and 25% of the total disease burden in children under five could be prevented through the reduction of environmental risks such as air pollution, unsafe water, sanitation and inadequate hygiene or chemicals.
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro...
The 2014-2015 outbreak of Ebola virus disease (EVD) in Liberia resulted in over 10,000 cases and 5,000 deaths. Recognizing the importance of addressing children’s trauma, the Ebola recovery and re...
